<div id="readability-page-1"><p>Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CFO Jeffrey Points acquired 995 shares of the business's stock in a transaction dated Thursday, December 11th. The stock was purchased at an average price of $14.65 per share, with a total value of $14,576.75. Following the completion of the transaction, the chief financial officer directly owned 53,440 shares of the company's stock, valued at $782,896. This trade represents a 1.90% increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink.</p><div><p><span></span><span>Get <strong>Shoulder Innovations</strong> alerts:</span></p></div><h2>Shoulder Innovations Price Performance</h2><ul><li>3 Mining Stocks Poised to Ride the Precious Metals Boom</li></ul><p>NYSE SI traded up $0.12 on Monday, hitting $14.49. The stock had a trading volume of 36,567 shares, compared to its average volume of 112,664. The business has a 50-day moving average of $13.43. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $17.94. </p><p>Shoulder Innovations (NYSE:SI - Get Free Report) last released its quarterly earnings results on Tuesday, November 11th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The firm had revenue of $11.76 million for the quarter, compared to analysts' expectations of $9.99 million.  On average, research analysts anticipate that  Shoulder Innovations, Inc. will post -0.56 EPS for the current year. </p><h2>Hedge Funds Weigh In On Shoulder Innovations</h2><ul><li>MarketBeat Week in Review – 7/8 - 7/12</li></ul><p>Several institutional investors and hedge funds have recently made changes to their positions in the business. Federated Hermes Inc. bought a new stake in  Shoulder Innovations in the third quarter worth $2,510,000.  Board of Trustees of The Leland Stanford Junior University purchased a new position in shares of  Shoulder Innovations in the third quarter worth about $170,000.  Rhumbline Advisers purchased a new position in shares of  Shoulder Innovations in the third quarter worth about $54,000.  TimesSquare Capital Management LLC bought a new stake in shares of  Shoulder Innovations in the 3rd quarter valued at about $4,799,000.  Finally, Vanguard Group Inc. purchased a new stake in  Shoulder Innovations during the 3rd quarter valued at about $1,836,000. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of brokerages have recently issued reports on SI. BTIG Research  reiterated a &#34;buy&#34; rating and set a $23.00 price target on shares of Shoulder Innovations in a research report on Tuesday, September 9th. Piper Sandler  reiterated an &#34;overweight&#34; rating and set a $18.00 target price on shares of Shoulder Innovations in a research report on Wednesday, November 12th. Wall Street Zen raised shares of Shoulder Innovations from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, October 11th. Jefferies Financial Group started coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set a &#34;buy&#34; rating and a $19.00 price objective on the stock. Finally, Zacks Research upgraded shares of Shoulder Innovations to a &#34;hold&#34; rating in a research report on Tuesday, August 26th. Five investment analysts have rated the stock with a Buy rating, one  has assigned  a Hold rating and one  has given a Sell rating to the company. Based on data from MarketBeat, Shoulder Innovations presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $20.60.</p><ul><li>New Theme Park Powerhouse: Merger Creates Industry-Leading Stock</li></ul><p><b>View Our Latest Stock Report on SI</b></p><h2>Shoulder Innovations Company Profile</h2> (Get Free Report)<p>We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.</p><h2>See Also</h2><ul><li>Five stocks we like better than Shoulder Innovations</li><li>The 3 Best Blue-Chip Stocks to Buy Now</li><li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li><li>Earnings Per Share Calculator: How to Calculate EPS</li><li>Is Nutanix the Best Comeback Trade Left in 2025? The Setup Says Yes</li><li>Growth Stocks: What They Are, What They Are Not</li><li>The Vertiv Pullback: Ignore the Noise, Buy the Data</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNJ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Shoulder Innovations Right Now?</h2><p>Before you consider Shoulder Innovations, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.</p><p>While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Shoulder Innovations CFO Jeffrey Points purchased 995 shares of the company's stock for $14,576.75, increasing his position by 1.90%. The transaction was disclosed in an SEC filing. The company's stock has a 52-week range of $10.92 to $17.94, and analysts have given it a "Moderate Buy" rating with an average target price of $20.60.</p>

Shoulder Innovations (NYSE:SI) CFO Purchases $14,576.75 in Stock